The aesthetic exosome market is growing rapidly and unevenly. Alongside genuinely well-characterised, rigorously manufactured Korean products with transparent documentation, the market contains preparations making compelling regenerative claims while providing minimal evidence of their actual content, source, or regulatory classification. For practitioners, the ability to evaluate exosome products on scientific and regulatory grounds is essential.

Exosomes are the most discussed new category in aesthetic medicine — and the category that most rewards a clear-eyed understanding of both the science and the considerable commercial noise that surrounds it.